Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGNDZ) Return on Assets (2016 - 2025)

Ligand Pharmaceuticals (LGNDZ) has disclosed Return on Assets for 14 consecutive years, with 0.08% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 11.0% to 0.08% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.08% through Dec 2025, up 11.0% year-over-year, with the annual reading at 0.1% for FY2025, 10.0% up from the prior year.
  • Return on Assets hit 0.08% in Q4 2025 for Ligand Pharmaceuticals, up from 0.04% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.08% in Q4 2025 to a low of 0.08% in Q1 2025.
  • Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2021.
  • Biggest five-year swings in Return on Assets: decreased -4bps in 2022 and later increased 11bps in 2025.
  • Year by year, Return on Assets stood at 0.01% in 2021, then crashed by -108bps to 0.03% in 2022, then skyrocketed by 93bps to 0.0% in 2023, then crashed by -1432bps to 0.03% in 2024, then skyrocketed by 350bps to 0.08% in 2025.
  • Business Quant data shows Return on Assets for LGNDZ at 0.08% in Q4 2025, 0.04% in Q3 2025, and 0.07% in Q2 2025.